Gábor Szabó

Gábor Szabó

Auto-generated profile, based on publicly available information

Gábor Szabó

Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2013 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
GSGábor Szabó
Gábor Szabó
BSBastian Schmack
Bastian Schmack
CBCem Bulut
Cem Bulut
PSPál Soós
Pál Soós
AWAlexander Weymann
Alexander Weymann
MKMatthias Karck
Matthias Karck
Constrictive pericarditis is the result of a spectrum of primary cardiac and non-cardiac conditions. Few data exist on the preoperative risk specific to survival after pericardiectomy. This study was designed to compare the association of aetiology of constrictive pericarditis and other clinical variables, with long-term survival after total pericardiectomy. A total of 89 patients were studied, who underwent pericardiectomy for constrictive pericarditis at a single surgical centre between 1988 and 2012. Constrictive pericarditis was confirmed by the surgical report. Demographic, pre-, intra- and postoperative data and long-term outcome were investigated. Survival was assessed by the Kaplan-Meier method. Aetiology of constrictive pericarditis was idiopathic in 49 patients (55%), prior cardiac surgery in 21 patients (23.6%), tuberculosis in 5 patients (5.6%), radiation treatment in 5 (5.6%), uraemia in 4 (4.5%), inflammation in 3 (3.5%) myocardial infarction in 2 (2.2%), and perioperative mortality was 7%. Seventy-five percent of patients were in New York Heart Association (NYHA) class III–IV, which status significantly improved in long-term survivors (95% in NYHA I–II). Idiopathic constrictive pericarditis had the best prognosis (5-year Kaplan-Meier survival: 81%) followed by post-surgical (50%) and post-radiation pericarditis (no survivors after 5 years). Tuberculosis, myocardial infarction and uraemia have survival rates comparable with idiopathic aetiology. In addition, preoperative NYHA class IV was associated with significantly lower long-term survival. Long-term survival after pericardiectomy for constrictive pericarditis is related to underlying aetiology and overall clinical condition. The relatively good survival with idiopathic constrictive pericarditis emphasizes the safety of pericardiectomy in this subgroup.

31 October 2015 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
CMCsaba Mátyás
Csaba Mátyás
BNBalázs Tamás Németh
Balázs Tamás Németh
AOAttila Oláh
Attila Oláh
LHLászló Hidi
László Hidi
EBEde Birtalan
Ede Birtalan
TRTamás Radovits
Tamás Radovits
Diabetes mellitus (DM) leads to the development of diabetic cardiomyopathy, which is associated with altered nitric oxide (NO)—soluble guanylate cyclase (sGC)—cyclic guanosine monophosphate (cGMP) signalling. Cardioprotective effects of elevated intracellular cGMP-levels have been described in different heart diseases. In the current study we aimed at investigating the effects of pharmacological activation of sGC in diabetic cardiomyopathy. Type-1 DM was induced in rats by streptozotocin. Animals were treated either with the sGC activator cinaciguat (10 mg/kg/day) or with placebo orally for 8 weeks. Left ventricular (LV) pressure–volume (P–V) analysis was used to assess cardiac performance. Additionally, gene expression (qRT-PCR) and protein expression analysis (western blot) were performed. Cardiac structure, markers of fibrotic remodelling and DNA damage were examined by histology, immunohistochemistry and TUNEL assay, respectively. DM was associated with deteriorated cGMP signalling in the myocardium (elevated phosphodiesterase-5 expression, lower cGMP-level and impaired PKG activity). Cardiomyocyte hypertrophy, fibrotic remodelling and DNA fragmentation were present in DM that was associated with impaired LV contractility (preload recruitable stroke work (PRSW): 49.5 ± 3.3 vs. 83.0 ± 5.5 mmHg, P < 0.05) and diastolic function (time constant of LV pressure decay (Tau): 17.3 ± 0.8 vs. 10.3 ± 0.3 ms, P < 0.05). Cinaciguat treatment effectively prevented DM related molecular, histological alterations and significantly improved systolic (PRSW: 66.8 ± 3.6 mmHg) and diastolic (Tau: 14.9 ± 0.6 ms) function. Cinaciguat prevented structural, molecular alterations and improved cardiac performance of the diabetic heart. Pharmacological activation of sGC might represent a new therapy approach for diabetic cardiomyopathy.

30 June 2009 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
KHKristof Hirschberg
Kristof Hirschberg
TRTamás Radovits
Tamás Radovits
SLSivakkanan Loganathan
Sivakkanan Loganathan
LELászló Entz
László Entz
CBCarsten J. Beller
Carsten J. Beller
GSGábor Szabó
Gábor Szabó

1 November 2002 in Artificial Organs
Verified
Journal Article
Closed access
PDF file
TATerézia Bogdana Andrási
Terézia Bogdana Andrási
VBVolker Buhmann
Volker Buhmann
PSPál Soós
Pál Soós
AJAlexander Juhász‐Nagy
Alexander Juhász‐Nagy
GSGábor Szabó
Gábor Szabó

1 March 2010 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
GSGábor Szabó
Gábor Szabó
GVGábor Veres
Gábor Veres
TRTamás Radovits
Tamás Radovits
HHHumaira Haider
Humaira Haider
NKNelli Krieger
Nelli Krieger
MKMatthias Karck
Matthias Karck

1 January 2010 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
GSGábor Szabó
Gábor Szabó
GVGábor Veres
Gábor Veres
TRTamás Radovits
Tamás Radovits
HHHumaira Haider
Humaira Haider
NKNelli Krieger
Nelli Krieger
ALAndreas van de Locht
Andreas van de Locht